Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M343Revenue $M9.3Net Margin (%)-217.3Altman Z-Score18.9
Enterprise Value $M332EPS $-0.4Operating Margin %-225.4Piotroski F-Score5
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)-213.1Higher ROA y-yY
Price/Book3.810-y EBITDA Growth Rate %-2.7Quick Ratio13.3Cash flow > EarningsY
Price/Sales36.95-y EBITDA Growth Rate %5.1Current Ratio13.3Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-19.3Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-20.9Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M50.6ROIC % (ttm)-41.8Gross Margin Increase y-yY

Gurus Latest Trades with CGEN

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

CGEN is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


CGEN: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about CGEN:

    News about CGEN:

    Articles On GuruFocus.com

    More From Other Websites
    Compugen First Quarter 2016 Conference Call and Webcast Scheduled for Tuesday, May 10, 2016 at 10:00... Apr 27 2016
    Compugen First Quarter 2016 Conference Call and Webcast Scheduled for Tuesday, May 10, 2016 at 10:00... Apr 27 2016
    Compugen Achieves Preclinical Milestone in Cancer Immunotherapy Collaboration with Bayer Apr 18 2016
    Compugen Achieves Preclinical Milestone in Cancer Immunotherapy Collaboration With Bayer Apr 18 2016
    Dr. Elliott Sigal Joins Compugen Ltd. as Strategic Advisor and Prof. Drew Pardoll Appointed Director... Apr 07 2016
    Dr. Elliott Sigal Joins Compugen Ltd. as Strategic Advisor and Prof. Drew Pardoll Appointed Director... Apr 06 2016
    Compugen to Present at the Jefferies Immuno-Oncology Summit in Boston Mar 28 2016
    Compugen to Present at the Jefferies Immuno-Oncology Summit in Boston Mar 28 2016
    COMPUGEN LTD Financials Mar 11 2016
    Compugen Presents Results for CGEN-15029 Immuno-Oncology Therapeutic Program Feb 29 2016
    Compugen Ltd. Earnings Analysis: 2015 By the Numbers Feb 10 2016
    Compugen reports 4Q loss Feb 09 2016
    Compugen reports 4Q loss Feb 09 2016
    Compugen Ltd. Reports Fourth Quarter and Calendar 2015 Results Feb 09 2016
    Compugen Fourth Quarter and Yearend 2015 Conference Call Scheduled for Tuesday, February 9, 2016 at... Jan 26 2016
    Compugen Fourth Quarter and Yearend 2015 Conference Call Scheduled for Tuesday, February 9, 2016 at... Jan 26 2016
    Compugen Ltd. breached its 50 day moving average in a Bullish Manner : January 6, 2016 Jan 06 2016
    Biotechnology Equities at a Glance -- Chimerix, Vitae Pharma, Aegerion Pharma, and Compugen Jan 05 2016
    Biotechnology Equities Update -- Arena Pharma, Compugen, ChemoCentryx, and Concert Pharma Dec 23 2015
    Compugen Ltd. Earnings Analysis: Q3, 2015 By the Numbers Dec 22 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)